(Reuters Health) - A years-long HIV outbreak among intravenous (IV) drug users in Indiana might have been avoided if the state's top medical and political leaders had acted sooner on early warnings that the virus was spreading, a recent study suggests.
Roche on Thursday said U.S. regulators approved expanded use of its drug Hemlibra to include almost all patients with hemophilia A, as the Swiss drugmaker increases its focus on diseases beyond cancer to help replace revenue from older products that have lost patent protection.
(Reuters Health) - People who regularly engage in light to moderate physical activity - like walking four hours a week or swimming two hours weekly - might have less severe strokes than individuals who aren't as active, a Swedish study suggests.
A U.S. unit of Brazil's JBS SA is recalling 6.5 million pounds of beef products processed through an Arizona plant because the meat might be contaminated with salmonella, U.S. government officials said on Thursday.
(Reuters Health) - Older white people with very impaired eyesight are more likely to use low-vision devices that may improve independence, compared to elderly people in other racial and ethnic groups, a U.S. study suggests.
Blackstone Group LP said on Thursday it has agreed to acquire life sciences investment firm Clarus, in an effort by the world's largest alternative asset manager to scale up its investments in healthcare.
Eli Lilly and Co said on Thursday its new two-in-one diabetes drug was successful in lowering blood sugar and reducing weight, sending its shares to a record high and weighing on those of arch-rival Novo Nordisk .
Arrowhead Pharmaceuticals Inc said on Thursday Johnson & Johnson would develop and market its gene-silencing Hepatitis B treatment and buy a minor stake in a deal that could be potentially worth more than $3.7 billion, sending its shares surging 20 percent.
Influenza drug baloxavir marboxil significantly sped time to relief for patients highly vulnerable to serious complications, a late-stage clinical trial has shown, Swiss drugmaker Roche said on Thursday.